Rewriting Your RNA

A DARPA-Funded Implantable Biochip To Detect COVID-19 Could Hit Markets By 2021   

Raul Diego, Mint Press News
Waking Times

The most significant scientific discovery since gravity has been hiding in plain sight for nearly a decade and its destructive potential to humanity is so enormous that the biggest war machine on the planet immediately deployed its vast resources to possess and control it, financing its research and development through agencies like the National Institutes of Health (NIH), the Defense Advanced Research Projects Agency (DARPA) and HHS’ BARDA.

The revolutionary breakthrough came to a Canadian scientist named Derek Rossi in 2010 purely by accident. The now-retired Harvard professor claimed in an interview with the National Post that he found a way to “reprogram” the molecules that carry the genetic instructions for cell development in the human body, not to mention all biological lifeforms.

These molecules are called ‘messenger ribonucleic acid’ or mRNA and the newfound ability to rewrite those instructions to produce any kind of cell within a biological organism has radically changed the course of Western medicine and science, even if no one has really noticed yet. As Rossi, himself, puts it: “The real important discovery here was you could now use mRNA, and if you got it into the cells, then you could get the mRNA to express any protein in the cells, and this was the big thing.”

It was so big that by 2014, Rossi was able to retire after the company he co-founded with Flagship Pioneering private equity firm to exploit his innovation, – Moderna Inc., attracted almost a half billion dollars in federal award monies to begin developing vaccines using the technology. No longer affiliated with Moderna beyond his stock holdings, Rossi is just “watching for what happens next” and if he’s anything like the doting “hockey dad” he is portrayed to be, he must be horrified.

Remote Control biology

As early as 2006, DARPA was already researching how to identify viral, upper respiratory pathogens through its Predicting Health and Disease (PHD) program, which led to the creation of the agency’s Biological Technologies Office (BTO), as reported by Whitney Webb in a May article for The Last American Vagabond. In 2014, DARPA’s BTO launched its “In Vivo Nanoplatforms” (IVN) program, which researches implantable nanotechnologies, leading to the development of ‘hydrogel’.

Hydrogel is a nanotechnology whose inventor early on boasted that “If [it] pans out, with approval from FDA, then consumers could get the sensors implanted in their core to measure their levels of glucose, oxygen, and lactate.” This contact lens-like material requires a special injector to be introduced under the skin where it can transmit light-based digital signals through a wireless network like 5G.

Once firmly implanted inside the body, human cells are at the mercy of any mRNA program delivered via this substrate, unleashing a nightmare of possibilities. It is, perhaps, the first true step towards full-on transhumanism; a “philosophy” that is in vogue with many powerful and influential people, such as Google’s Ray Kurzweil and Eric Schmidt and whose proponents see the fusion of technology and biology as an inevitable consequence of human progress.

The private company created to market this technology, that allows for biological processes to be controlled remotely and opens the door to the potential manipulation of our biological responses and, ultimately, our entire existence, is called Profusa Inc and its operations are funded with millions from NIH and DARPA. In March, the company was quietly inserted into the crowded COVID-19 bazaar in March 2020, when it announced an injectable biochip for the detection of viral respiratory diseases, including COVID-19.

A wholly-owned subsidiary

In July, a preliminary report funded by Fauci’s NIAID and the NIH on an mRNA Vaccine against SARS-CoV-2 was published in The New England Journal of Medicine, concluding that mRNA-1273 vaccine. provided by Moderna for the study, “induced anti–SARS-CoV-2 immune responses in all participants, and no trial-limiting safety concerns were identified,” and supported “further development of this vaccine.”

A month earlier, the NIH had claimed a joint stake in Moderna’s mRNA COVID-19 vaccine, citing a contract signed in December, 2019, stipulating that the “mRNA coronavirus vaccine candidates [are] developed and jointly owned” by both parties. Moderna disputes the federal government’s position, stating that the company “has a broad owned and licensed IP estate” and is “not aware of any IP that would prevent us from commercializing our product candidates, including mRNA-1273.”

The only obstacle is a delivery system, which though Moderna claims to be developing separately, is unlikely to get FDA approval before the federal government’s own DARPA-developed hydrogel technology, in tandem with Profusa’s DARPA-funded light sensor technology, which is expected to receive fast track authorization from the Food and Drug Administration by early 2021 and, more than likely, used to deploy a coronavirus vaccine with the capacity to literally change our DNA.

In addition, the Department of Health and Human Services (HHS), is currently investigating Moderna’s patent filings, claiming it failed to disclose “federal government support” in its COVID vaccine candidate patent applications, as required by law. The technicality could result in the federal government owning a 100 percent stake in mRNA-1273.

 

 

About the Author

Raul Diego is a MintPress News Staff Writer, independent photojournalist, researcher, writer and documentary filmmaker.

from:    https://www.wakingtimes.com/2020/09/21/a-darpa-funded-implantable-biochip-to-detect-covid-19-could-hit-markets-by-2021/

“THEY” Do Not Want an Effective and Inexpensive Treatment -No $$$ For Them

An Effective COVID Treatment the Media Continues to Besmirch

August 04, 2020

An Effective COVID Treatment the Media Continues to Besmirch
(AP Photo/Rafiq Maqbool)

On Friday, July 31, in a column ostensibly dealing with health care “misinformation,” Washington Post media critic Margaret Sullivan opened by lambasting “fringe doctors spouting dangerous falsehoods about hydroxychloroquine as a COVID-19 wonder cure.”

Actually, it was Sullivan who was spouting dangerous falsehoods about this drug, something the Washington Post and much of the rest of the media have been doing for months. On May 15, the Post offered a stark warning to any Americans who may have taken hope in a possible therapy for COVID-19. In the newspaper’s telling, there was nothing unambiguous about the science — or the politics — of hydroxychloroquine: “Drug promoted by Trump as coronavirus game-changer increasingly linked to deaths,” blared the headline. Written by three Post staff writers, the story asserted that the effectiveness of hydroxychloroquine in treating COVID-19 is scant and that the drug is inherently unsafe.

This claim is nonsense

Biased against the use of hydroxychloroquine for COVID-19 — and the Washington Post is hardly alone — the paper described an April 21, 2020, drug study on U.S. Veterans Affairs patients hospitalized with the illness. It found a high death rate in patients taking the drug hydroxychloroquine. But this was a flawed study with a small sample, the main flaw being that the drug was given to the sickest patients who were already dying because of their age and severe pre-existing conditions. This study was quickly debunked. It had been posted on a non-peer-reviewed medical archive that specifically warns that studies posted on its website should not be reported in the media as established information.

Yet, the Post and countless other news outlets did just the opposite, making repeated claims that hydroxychloroquine was ineffective and caused serious cardiac problems. Nowhere was there any mention of the fact that COVID-19 damages the heart during infection, sometimes causing irregular and sometimes fatal heart rhythms in patients not taking the drug.

To a media unrelentingly hostile to Donald Trump, this meant that the president could be portrayed as recklessly promoting the use of a “dangerous” drug. Ignoring the refutation of the VA study in its May 15 article, the Washington Post cited a Brazil study published on April 24 in which a COVID trial using chloroquine (a related but different drug than hydroxychloroquine) was stopped because 11 patients treated with it died. The reporters never mentioned another problem with that study: The Brazilian doctors were giving their patients lethal cumulative doses of the drug.

On and on it has gone since then, in a circle of self-reinforcing commentary. Following the news that Trump was taking the drug himself, opinion hosts on cable news channels launched continual attacks on both hydroxychloroquine and the president. “This will kill you!” Fox News Channel’s Neil Cavuto exclaimed. “The president of the United States just acknowledge that he is taking hydroxychloroquine, a drug that [was] meant really to treat malaria and lupus.”

Washington Post reporters Ariana Cha and Laurie McGinley were back again on May 22, with a new article shouting out the new supposed news: “Antimalarial drug touted by President Trump is linked to increased risk of death in coronavirus patients, study says.” The media uproar this time was based on a large study just published in the Lancet. There was just one problem. The Lancet paper was fraudulent and it was quickly retracted.

However, the damage from the biased media storm was done and it was long-lasting. Continuing patient enrollment needed for early-use clinical trials of hydroxychloroquine dried up within a week. Patients were afraid to take the drug, doctors became afraid to prescribe it, pharmacies refused to fill prescriptions, and in a rush of incompetent analysis and non-existent senior leadership, the FDA revoked its Emergency Use Authorization for the drug.

So what is the real story on hydroxychloroquine? Here, briefly, is what we know:

When the COVID-19 pandemic began, a search was made for suitable antiviral therapies to use as treatment until a vaccine could be produced. One drug, hydroxychloroquine, was found to be the most effective and safe for use against the virus. Federal funds were used for clinical trials of it, but there was no guidance from Dr. Anthony Fauci or the NIH Treatment Guidelines Panel on what role the drug would play in the national pandemic response. Fauci seemed to be unaware that there actually was a national pandemic plan for respiratory viruses.

Following a careful regimen developed by doctors in France, some knowledgeable practicing U.S. physicians began prescribing hydroxychloroquine to patients still in the early phase of COVID infection. Its effects seemed dramatic. Patients still became sick, but for the most part they avoided hospitalization. In contrast — and in error — the NIH-funded studies somehow became focused on giving hydroxychloroquine to late-presenting hospitalized patients. This was in spite of the fact that unlike the drug’s early use in ambulatory patients, there was no real data to support the drug’s use in more severe hospitalized patients.

By April, it was clear that roughly seven days from the time of the first onset of symptoms, a COVID-19 infection could sometimes progress into a more radical late phase of severe disease with inflammation of the blood vessels in the body and immune system over-reactions. Many patients developed blood clots in their lungs and needed mechanical ventilation. Some needed kidney dialysis. In light of this pathological carnage, no antiviral drug could be expected to show much of an effect during this severe second stage of COVID.

On April 6, 2020, an international team of medical experts published an extensive study of hydroxychloroquine in more than 130,000 patients with connective tissue disorders. They reaffirmed that hydroxychloroquine was a safe drug with no serious side effects. The drug could safely be given to pregnant women and breast-feeding mothers. Consequently, countries such as China, Turkey, South Korea, India, Morocco, Algeria, and others began to use hydroxychloroquine widely and early in their national pandemic response. Doctors overseas were safely prescribing the drug based on clinical signs and symptoms because widespread testing was not available.

However, the NIH promoted a much different strategy for the United States. The “Fauci Strategy” was to keep early infected patients quarantined at home without treatment until they developed a shortness of breath and had to be admitted to a hospital. Then they would they be given hydroxychloroquine. The Food and Drug Administration cluelessly agreed to this doctrine and it stated in its hydroxychloroquine Emergency Use Authorization (EUA) that “hospitalized patients were likely to have a greater prospect of benefit (compared to ambulatory patients with mild illness).”

In reality just the opposite was true. This was a tragic mistake by Fauci and FDA Commissioner Dr. Stephen Hahn and it was a mistake that would cost the lives of thousands of Americans in the days to come.

At the same time, accumulating data showed remarkable results if hydroxychloroquine were given to patients early, during a seven-day window from the time of first symptom onset. If given during this window, most infections did not progress into the severe, lethal second stage of the disease. Patients still got sick, but they avoided hospitalization or the later transfer to an intensive care unit. In mid-April a high-level memo was sent to the FDA alerting them to the fact that the best use for hydroxychloroquine was for its early use in still ambulatory COVID patients. These patients were quarantined at home but were not short of breath and did not yet require supplemental oxygen and hospitalization.

Failing to understand that COVID-19 could be a two-stage disease process, the FDA ignored the memo and, as previously mentioned, it withdrew its EUA for hydroxychloroquine based on flawed studies and clinical trials that were applicable only to late-stage COVID patients.

By now, however, some countries had already implemented early, aggressive, outpatient community treatment with hydroxychloroquine and within weeks were able to minimize their COVID deaths and bring their national pandemic under some degree of control.

In countries such as Great Britain and the United States, where the “Fauci-Hahn Strategy” was followed, there was a much higher death rate and an ever-increasing number of cases. COVID patients in the U.S. would continue to be quarantined at home and left untreated until they developed shortness of breath. Then they would be admitted to the hospital and given hydroxychloroquine outside the narrow window for the drug’s maximum effectiveness.

In further contrast, countries that started out with the “Fauci-Hahn Doctrine” and then later shifted their policy towards aggressive outpatient hydroxychloroquine use, after a brief lag period also saw a stunning rapid reduction in COVID mortality and hospital admissions.

Finally, several nations that had started using an aggressive early-use outpatient policy for hydroxychloroquine, including France and Switzerland, stopped this practice when the WHO temporarily withdrew its support for the drug. Five days after the publication of the fake Lancet study and the resulting media onslaught, Swiss politicians banned hydroxychloroquine use in the country from May  27 until June 11, when it was quickly reinstated.

The consequences of suddenly stopping hydroxychloroquine can be seen by examining a graph of the Case Fatality Ratio Index (nrCFR) for Switzerland. This is derived by dividing the number of daily new COVID fatalities by the new cases resolved over a period with a seven-day moving average. Looking at the evolution curve of the CFR it can be seen that during the weeks preceding the ban on hydroxychloroquine, the nrCFR index fluctuated between 3% and 5%.

Following a lag of 13 days after stopping outpatient hydroxychloroquine use, the country’s COVID-19 deaths increased four-fold and the nrCFR index stayed elevated at the highest level it had been since early in the COVID pandemic, oscillating at over 10%-15%. Early outpatient hydroxychloroquine was restarted June 11 but the four-fold “wave of excess lethality” lasted until June 22, after which the nrCFR rapidly returned to its background value.

Here in our country, Fauci continued to ignore the ever accumulating and remarkable early-use data on hydroxychloroquine and he became focused on a new antiviral compound named remdesivir. This was an experimental drug that had to be given intravenously every day for five days. It was never suitable for major widespread outpatient or at-home use as part of a national pandemic plan. We now know now that remdesivir has no effect on overall COVID patient mortality and it costs thousands of dollars per patient.

Hydroxychloroquine, by contrast, costs 60 cents a tablet, it can be taken at home, it fits in with the national pandemic plan for respiratory viruses, and a course of therapy simply requires swallowing three tablets in the first 24 hours followed by one tablet every 12 hours for five days.

There are now 53 studies that show positive results of hydroxychloroquine in COVID infections. There are 14 global studies that show neutral or negative results — and 10 of them were of patients in very late stages of COVID-19, where no antiviral drug can be expected to have much effect. Of the remaining four studies, two come from the same University of Minnesota author. The other two are from the faulty Brazil paper, which should be retracted, and the fake Lancet paper, which was.

Millions of people are taking or have taken hydroxychloroquine in nations that have managed to get their national pandemic under some degree of control. Two recent, large, early-use clinical trials have been conducted by the Henry Ford Health System and at Mount Sinai showing a 51% and 47% lower mortality, respectively, in hospitalized patients given hydroxychloroquine. A recent study from Spain published on July 29, two days before Margaret Sullivan’s strafing of “fringe doctors,” shows a 66% reduction in COVID mortality in patients taking hydroxychloroquine. No serious side effects were reported in these studies and no epidemic of heartbeat abnormalities.

This is ground-shaking news. Why is it not being widely reported? Why is the American media trying to run the U.S. pandemic response with its own misinformation?

Steven Hatfill is a veteran virologist who helped establish the Rapid Hemorrhagic Fever Response Teams for the National Medical Disaster Unit in Kenya, Africa. He is an adjunct assistant professor in two departments at the George Washington University Medical Center where he teaches mass casualty medicine. He is principle author of the prophetic book “Three Seconds Until Midnight — Preparing for the Next Pandemic,” published by Amazon in 2019.

from:    https://www.realclearpolitics.com/articles/2020/08/04/an_effective_covid_treatment_the_media_continues_to_besmirch_143875.html

Cui Bono, Dr. Faustus, oops Fauci???

Dr. Fauci’s Attempt to Silence Whistleblower Dr. Judy Mikovits Which Destroyed her Career

The Truth About Fauci—Featuring Dr. Judy Mikovits

“Judy Mikovits is Among Her Generation’s Most Accomplished Scientists.” —Robert F. Kennedy, Jr.

by Robert F. Kennedy, Jr., Chairman
Children’s Health Defense

Dr. Mikovits joined NIH in 1980 as a Postdoctoral Scholar in Molecular Virology at the National Cancer Institute and began a 20-year collaboration with Frank Ruscetti, a pioneer in the field of human retro virology. She helped Dr Russetti isolate the HIV virus and link it to #AIDS in 1983. Her NIH boss Anthony Fauci delayed publication of that critical paper for 6 months to let his protégé Robert Gallo replicate, publish and claim credit. The delay in mass HIV testing let AIDS further spread around the globe and helped Fauci win promotion to director NIAID.

In 2006, Dr Mikovits became director of Whittemore Peterson Institute for Neuro-Immune Disease and collaborated with Dr Ruscetti searching for the cause of Chronic Fatigue Syndrome which suddenly became epidemic in the 1980s. The male dominated medical community dismissed CFS as psychosomatic “yuppie flu” caused when fragile females cracked in corporate jobs.

Dr. Mikovits discovered that 67% of affected women carried a virus—called Xenotropic Murine Leukemia related Virus—that appeared in healthy women only 4% of the time.

XMRV is also associated with prostate, breast, ovarian cancers, leukemia, and multiple myeloma. Many women with XMRV bore children with autism.

In 2009, Drs. Mikovits and Ruscetti published their explosive findings in the journal Science. But the question remained: how was XMRV getting into people?

Other researchers linked the first CFS outbreak to a polio vaccine given to doctors and nurses that resulted in the “1934 Los Angeles County Hospital Epidemic.” That vaccine was cultivated on pulverized mouse brains. Retroviruses from dead animals can survive in cell lines and permanently contaminate vaccines.

Dr Mikovits’ studies suggested that the XMRV Virus was present in the MMR, Polio and Encephalitis vaccines given to American children and soldiers. XMRV is so hazardous that the mere presence of mouse tissue in a laboratory can contaminate other tissues in the same room.

Dr Fauci ordered Mikovits to keep her mouth shut. When she refused, he illegally confiscated her work books and hard drives, drove her from government work and blackballed her from receiving NIH grants ending her science career. XMRV remains in American vaccines.

Video Transcript

The Truth About Fauci, featuring Judy Mikovits, Joint PhD in Biochemistry and Molecular Biology, George Washington University; Postdoctoral Scholar in Molecular Virology National Cancer Institute; Research Director of Whittemore Peterson Institute for Neuro-Immune Disease and target of Anthony Fauci—Twice.

In Washington DC Fauci’s tactics are an open secret. Intimidation. Bullying. And reckless disregard for the health and safety of the American people.

Dr. Judy Mikovits was one of the most skilled scientists of her generation. She had a 20-year collaboration with Frank Ruscetti, a pioneer in the field of human retro virology.

The first Fauci episode:

Mikovits: I took a job at the National Cancer Institute. I was under the direction of Frank Ruscetti. I isolated HIV from blood and saliva confirming Dr. Luc Montagnier’s earlier isolation and description of HIV as a possible causative agent of AIDS. I refused to do that because it’s unethical.

And then, Anthony Fauci intervened.

Mikovits: When Frank Ruscetti was out of town, I received a call from Dr. Fauci and he demanded that I give him our manuscript on the isolation and confirmation of HIV, while it was still in press. I refused to do that because it’s unethical. These manuscripts are confidential and only authors can give him a copy.

Dr. Mikovits’ standards of ethics and moral courage are unparalleled.

Mikovits: He threatened to fire me for insubordination but still I refused. It’s unethical.

Mikovits: When Frank Ruscetti returned a few weeks later, he gave the manuscript to Dr. Fauci, and Dr. Fauci purposely delayed the publication of our manuscript in order that his crony, Dr. Robert Gallo, could copy our work and submit a competing manuscript and get it into press before ours.

On May 4, 1984, Dr. Robert Gallo famously published a series of papers demonstrating that a retrovirus he’d isolated was the cause of AIDS.

Appropriating her work wasn’t the worst of it. This delayed the development of testing and spread the HIV epidemic through the world, killing millions.

Driven by greed and cronyism, Anthony Fauci—”America’s Doctor”—is directly responsible for the further spread of HIV throughout the world.

Rather than being punished for his actions, six months later he was appointed Director of the National Institute of Allergy and Infectious Diseases–a position he still holds today.

The second Fauci episode:

Mikovits: In 2006 I co-founded and developed the first neuroimmune disease institute to study the cause and treatments of chronic fatigue syndrome.

Chronic Fatigue Syndrome became epidemic in the 1980s. Doctors dismissed the ailment as psychosomatic “yuppie flu.” CFS primarily struck women. The medical community assumed they were physically and emotionally fragile and cracked under the pressure of corporate jobs.

Dr. Mikovits discovered that 67% of women affected with CFS carried a mouse virus–called XMRV– Xenotropic Murine Leukemia related Virus–that appeared in healthy women only 4% of the time.  XMRV is also associated with cancers like prostate, breast, ovarian, leukemia, and multiple myeloma. Many women with XMRV go on to have children with autism.

In 2009, Drs. Mikovits and Ruscetti published their explosive findings in the journal Science. But the question remained: how was XMRV getting into people?

Mikovits: Then in 2011, our research strongly suggested that it entered the human virome through a contaminated blood supply and vaccines.

Other researchers linked the first CFS outbreak to a polio vaccine given to doctors and nurses that resulted in the “1934 Los Angeles County Hospital Epidemic.” That vaccine was cultivated on pulverized mouse brains. Retroviruses from dead animals can survive in cell lines and permanently contaminate vaccines.

Retroviruses from those dead animals can survive in cell lines and permanently contaminate the vaccines.

XMRV is so hazardous that the mere presence of mouse tissue in a laboratory can contaminate other tissues in the same room.

Dr. Mikovits’ studies suggested XMRV is present in the MMR and polio vaccines given to American children and the Japanese encephalitis vaccine given to military personnel.

The dangers of mouse brain derived vaccines are now widely acknowledged.

“… mouse brain derived vaccine has been associated with serious allergic and neurologic adverse events.” –American Academy of Pediatrics

Mikovits: We recognized that this mouse retrovirus was causing an alarming national health crisis. That is if the blood supply and vaccines were heavily contaminated with mouse retroviruses of many strains.

As Dr. Mikovits and her team prepared to sound the alarm, Dr. Fauci used his power to silence her.

Mikovits: What Tony Fauci, Ian Lipkin and Harold Varmus did was pressure me to be silent and withdraw our manuscript. I refused again.

Anthony Fauci gave his own career and the vaccine program priority above the health and safety of all Americans.

Mikovits: When I refused to be silent, Dr. Fauci stepped in and ordered that my computers and notebooks be confiscated and orchestrated the retraction of our science paper.

Dr. Fauci abused his power and misused his office.

Mikovits: He then removed all of my funding and prevented me from getting a job in government research from 2012 forward.

Hundreds of millions of Americans may have received vaccines contaminated with XMRV.

Anthony Fauci has failed us.

Are you prepared to trust him?

Join the movement.

Read the full article at ChildrensHealthDefense.org.

Comment on this article at HealthImpactNews.com.

© 2020 Children’s Health Defense, Inc.

This work is reproduced and distributed with the permission of Children’s Health Defense, Inc.

from:   https://vaccineimpact.com/2020/dr-faucis-attempt-to-silence-whistleblower-dr-judy-mikovits-which-destroyed-her-career/